Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory

Clinical and Laboratory Haematology

Volumn 27, Issue 4, 2005, Pages 258-266

  Gibbs, Graham ^a,b   Bromidge, T ^a   Howe, D ^a   Hopkins, J ^a   Johnson, S ^a  

^a TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Flow cytometry; Immunoglobulin VH genes; Prognosis; ZAP 70

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LABORATORY TECHNIQUES AND PROCEDURES; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; PROTEIN-TYROSINE KINASES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 23444453040     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00703.x     Document Type: Article

References (26)

1. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S. & Gremy F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48, 198-206.
2. Chan A.C., Iwashima M., Turck C.W. & Weiss A. (1992) ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 71, 649-662.
3. Chen L., Widhopf G., Huynh L., Rassenti L., Rai K.R., Weiss A. & Kipps T.J. (2002) Expression of ZAP-70 is associated with increased B-cell receptor signalling in chronic lymphocytic leukemia. Blood 100, 4609-4614.
4. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S. & Rai K.R. (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87, 4990-4997.
5. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., Marce S., Lopez-Guillermo A., Campo E. & Montserrat E. (2003) ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. New England Journal of Medicine 348, 1764-1775.
6. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S.M., Schulman P., Vinciguerra V.P., Rai K.R., Ferrarini M. & Chiorazzi N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94, 1840-1847.
7. Durig J., Nuckel H., Cremer M., Fuhrer A., Halfmeyer K., Fandrey J., Moroy T., Klein-Hitpass L. & Duhrsen U. (2003) ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 17, 2426-2434.
8. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94, 1848-1854.
9. Hamblin T.J., Orchard J.A., Gardiner A., Oscier D.G., Davis Z. & Stevenson F.K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood 95, 2455-2456.
10. Howe D.J., Bromidge T.J., Stack-Dunne M., Davies S.V., Paxton A., Phillips M., Rule S.J. & Johnson S.A. (1997) Trisomy 12 is a rare event in cases of CLL with typical immunophenotype and morphology. Hematology 2, 373-378.
11. Ibrahim S., Keating M., Do K., O'Brien S., Huh Y.O., Jilani I., Lerner S., Kantarjian H.M. & Albitar M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukaemia. Blood 98, 181-186.
12. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., freedman, A., Inghirami, G., Cro, L., Baldini, L., Neri, A., Califano, A. & Dalla-Favera R. (2001) Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogenous phenotype related to memory B cells. Journal of Experimental Medicine 194, 1625-1638.
13. H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 100, 1410-1416.
14. Krutzik P.O. & Nolan G.P. (2003) Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signalling events. Cytometry 55A, 61-70.
15. H mutation in chronic lymphocytic leukemia. Blood 100, 1404-1409.
16. Manocha S., Matrai Z., Osthoff M., Carter A. & Pettitt A.R. (2003) Correlation between cell size and CD38 expression in chronic lymphocytic leukaemia. Leukemia & Lymphoma 44, 797-800.
17. Montserrat E. (2002) Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now? The Hematology Journal 3, 7-9.
18. Orchard J.A., Ibbotson R.E., Davis Z., Wiestner A., Rosenwald A., Thomas P.W., Hamblin T.J., Staudt L.M. & Oscier D.G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. The Lancet 363, 105-111.
19. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N. & Pasternack B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood 46, 219-234.
20. Rassenti L.Z., Lang Huynh B.S., Toy T.L., Chen L., Keating M.J., Gribben J.G., Neuberg D.S., Flinn I.W., Rai K.R., Byrd J.C., Kay N.E., Greaves A., Weiss A. & Kipps T.J. (2004) ZAP-70 compared with immunoglobulin heavy-chain mutation status as a predictor of disease progression in chronic lymphocytic leukemia. New England Journal of Medicine 351, 893-901.
21. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., Yang L., Pickeral O.K., Rassenti L.Z., Powell J., Botstein D., Byrd J.C., Grever M.R., Cheson B.D., Chiorazzi N., Wilson W.H., Kipps T.J., Brown P.O. & Staudt L.M. (2001) Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. Journal of Experimental medicine 194, 1639-1647.
22. Stilgenbauer S., Krober A., Seiler T., Benner A., Bullinger L., Bruckle E., Lichter P. & Dohner H. (2001) VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 98, 472a.
23. Thornton P.D., Fernandez C., Giustolisi G.M., Morilla R., Atkinson S., A'Hern R.P., Matutes E. & Catovsky D. (2004) CD38 expression as a prognostic indicator in chronic lymphocytic leukaemia. The Hematology Journal 5, 145-151.
24. H 3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 99, 2262-2264.
25. Turner M., Schweighoffer E., Colucci F., Di Santo J.P. & Tybulewicz V.L. (2000) Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunology Today 21, 148-154.
26. Weistner A., Rosenwald A., Barry T.S., Wright G., Davis R.E., Henrickson S.E., Zhao H., Ibbotson R.E., Orchard J.A., Davis Z., Stetler-Stevenson M., Raffeld M., Arthur D.C., Marti G.E., Wilson W.H., Hamblin T.J., Oscier D.G. & Staudt L.M. (2003) ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101, 4944-4951.